WD Lab Grown Diamonds Acquires J2 Materials

Huron Capital Makes Equity Investment in WD Lab Grown Diamonds

January 7, 2019

Manufacturing

Huron Capital, a Detroit-based middle-market private equity firm, completed a significant equity investment in WD Lab Grown Diamonds, a Washington, D.C.-area producer of high-quality Chemical Vapor Deposition (CVD) diamonds. The capital will be used to expand WD's production capacity and support growth across gem, retail/wholesale and industrial/scientific end markets while founder-management remain significant shareholders.

John Crane Acquires Industrial Division of Advanced Diamond Technologies

April 18, 2019

Manufacturing

John Crane acquired the Industrial Division of Advanced Diamond Technologies (ADT), based in Romeoville, Illinois, bringing ADT's ultrananocrystalline diamond (UNCD) thin-film technology into John Crane's product portfolio. The acquisition is intended to enhance John Crane's mechanical-seal performance in harsh applications by integrating ADT's proprietary diamond-facing processes and materials.

Mitsui & Co. Acquires Dermaceutical Laboratories (D-LAB)

August 21, 2023

Consumer Products

Mitsui & Co., Ltd. has agreed to acquire all shares of Dermaceutical Laboratories, LLC (D-LAB), a Bergen County, New Jersey-based cosmetics ODM and contract manufacturer. Mitsui will position D-LAB as the core beauty & personal care (BPC) business in the Americas, leveraging Japanese technologies and Mitsui's procurement and global network to expand capabilities and scale in the U.S. market.

Lunovus Acquires Diamond Studios

November 17, 2023

Software

Lunovus LLC, a physician-owned eyecare software and supplementation company based in Birmingham, Alabama, has acquired Diamond Studios, a 41-year-old software development and media firm. The acquisition strengthens Lunovus' software solution portfolio—including support and further development of the Doc2Home platform—while Diamond Studios will continue operating under its brand with Joe Miele leading daily operations.

Element Materials Technology Acquires JMI Laboratories

January 14, 2022

Healthcare Services

Element Materials Technology has acquired JMI Laboratories, a North Liberty, Iowa-based microbiology and molecular testing provider known for its SENTRY Antimicrobial Surveillance Program. The acquisition is an add-on to Element's life sciences buildout, expanding its pharmaceutical and biopharmaceutical testing capabilities across North America and Europe.

Genesis Drug Discovery & Development (GD3) Acquires JSS Medical Research

May 10, 2023

Healthcare Services

Genesis Drug Discovery & Development (GD3), a member of Genesis Global Group (GGG), has acquired Montreal-headquartered JSS Medical Research to expand GD3's clinical services and create a more vertically integrated drug research and development platform. The acquisition adds JSS's clinical trial management, biostatistics, data management, medical writing and safety services to GD3/GGG's existing discovery and development capabilities, supporting broader geographic reach and enhanced end-to-end offerings for pharmaceutical, biotechnology and medical device clients.